Virginia Retirement Systems’s Stoke Therapeutics STOK Stock Holding History

Virginia Retirement Systems’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$208K	Buy	+6,550	New	+$197K	﹤0.01%	912
2023 Q3	$58.7K	Sell	14,900 -700	-4%	-$4.6K	﹤0.01%	932
2023 Q2	$166K	Sell	15,600 -300	-2%	-$3.19K	﹤0.01%	933
2023 Q1	$132K	Sell	15,900 -1,200	-7%	-$10.8K	﹤0.01%	989
2022 Q4	$158K	Buy	17,100 +1,900	+13%	+$19.8K	﹤0.01%	1074
2022 Q3	$195K	Buy	+15,200	New	+$242K	﹤0.01%	1062
2022 Q1	$322K	Buy	+15,300	New	+$306K	﹤0.01%	959

Other funds holding STOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virginia Retirement Systems's STOK Position: Q4 2025 in Review

Virginia Retirement Systems opened a new position in Stoke Therapeutics (STOK) in Q4 2025: 6,550 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #912 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in STOK as recently as Q3 2023.

Virginia Retirement Systems first reported a position in STOK in Q1 2022 and has held it in 7 quarters since. The position peaked at $322K in Q1 2022. 183 funds tracked by Wall St. Rank hold STOK as of Q4 2025.

Virginia Retirement Systems held 6,550 shares of Stoke Therapeutics worth $208K as of Q4 2025.
Stoke Therapeutics was a new Virginia Retirement Systems position in Q4 2025.
Stoke Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #912 holding.
Virginia Retirement Systems first reported a position in Stoke Therapeutics in Q1 2022 and has held it in 7 quarters since.
Virginia Retirement Systems's Stoke Therapeutics position peaked at $322K in Q1 2022.
183 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.